(Q39236344)

10 September 2017

title

Depletion of β-arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway (English)

1 reference

10 September 2017

Wu-Yi Sun

1

1 reference

10 September 2017

Yang Song

2

1 reference

10 September 2017

Shan-Shan Hu

3

1 reference

10 September 2017

Qing-Tong Wang

4

1 reference

10 September 2017

Hua-Xun Wu

5

1 reference

10 September 2017

Jing-Yu Chen

6

1 reference

10 September 2017

Wei Wei

7

1 reference

10 September 2017

publication date

1 May 2013

1 reference

Journal of Cellular Biochemistry

10 September 2017

published in

1 reference

10 September 2017

volume

114

1 reference

10 September 2017

issue

5

1 reference

10 September 2017

page(s)

1153-1162

1 reference

SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-β1 and PDGF

10 September 2017

cites work

1 reference

Beta-arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFkappaB gene expression network in osteoblasts

21 January 2018

1 reference

Arrestin orchestrates crosstalk between G protein-coupled receptors to modulate the spatiotemporal activation of ERK MAPK.

21 January 2018

1 reference

Anti-fibrotic effects of the anthocyanins isolated from the purple-fleshed sweet potato on hepatic fibrosis induced by dimethylnitrosamine administration in rats

21 January 2018

1 reference

The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8.

21 January 2018

1 reference

A single mutation in arrestin-2 prevents ERK1/2 activation by reducing c-Raf1 binding.

21 January 2018

1 reference

Therapeutic targets in liver fibrosis

21 January 2018

1 reference

Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cells

21 January 2018

1 reference

Antidepressants, beta-arrestins and GRKs: from regulation of signal desensitization to intracellular multifunctional adaptor functions

21 January 2018

1 reference

Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases

21 January 2018

1 reference

Pathogenesis of liver fibrosis

21 January 2018

1 reference

The role of dystroglycan in PDGF-BB-dependent migration of activated hepatic stellate cells/myofibroblasts

21 January 2018

1 reference

Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats

21 January 2018

1 reference

Effect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cells

21 January 2018

1 reference

Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2.

21 January 2018

1 reference

Phosphorylation barcoding as a mechanism of directing GPCR signaling

21 January 2018

1 reference

Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258

21 January 2018

1 reference

Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib.

21 January 2018

1 reference

Beta-arrestin signaling and regulation of transcription

21 January 2018

1 reference

Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3

21 January 2018

1 reference

Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis

21 January 2018

1 reference

Regulation of MAP Kinase Signaling Modules by Scaffold Proteins in Mammals

21 January 2018

1 reference

The active conformation of beta-arrestin1: direct evidence for the phosphate sensor in the N-domain and conformational differences in the active states of beta-arrestins1 and -2

21 January 2018

1 reference

Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*

21 January 2018

1 reference

Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta

21 January 2018

1 reference

Update on the pathophysiology of liver fibrosis

21 January 2018

1 reference

Experimental systems for studying the role of G-protein-coupled receptors in receptor tyrosine kinase signal transduction

21 January 2018

1 reference

Arrestins block G protein-coupled receptor-mediated apoptosis

21 January 2018

1 reference

Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis

21 January 2018

1 reference

Hepatic stellate cell (vitamin A-storing cell) and its relative--past, present and future

21 January 2018

1 reference

beta-Arrestins modulate Adenovirus-vector-induced innate immune responses: differential regulation by beta-arrestin-1 and beta-arrestin-2.

21 January 2018

1 reference

Suppressive effect of leflunomide on rat hepatic stellate cell proliferation involves on PDGF-BB-elicited activation of three mitogen-activated protein kinases

21 January 2018

1 reference

Regulated Expression of G Protein-Coupled Receptor Kinases (GRK?s) and ?-Arrestins in Osteoblasts

21 January 2018

1 reference

Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation

21 January 2018

1 reference

Beta-arrestin 2 modulates resveratrol-induced apoptosis and regulation of Akt/GSK3ß pathways

21 January 2018

1 reference

Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.24458

1 reference

10 September 2017

1 reference